Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
71.63
+0.09 (0.13%)
Dec 5, 2025, 4:00 PM EST - Market closed
Avidity Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 10,793 | 3,470 | 671 | 1,474 | 1,115 | 958 | |
| Market Cap Growth | 109.16% | 417.36% | -54.52% | 32.27% | 16.40% | - | |
| Enterprise Value | 8,967 | 1,889 | 139 | 1,080 | 703 | 617 | |
| Last Close Price | 71.63 | 29.08 | 9.05 | 22.19 | 23.77 | 25.52 | |
| PS Ratio | 517.20 | 318.39 | 70.15 | 159.85 | 119.53 | 141.10 | |
| PB Ratio | 5.57 | 2.44 | 1.34 | 2.55 | 2.92 | 3.13 | |
| P/TBV Ratio | 5.72 | 2.44 | 1.34 | 2.55 | 2.92 | 3.13 | |
| EV/Sales Ratio | 429.70 | 173.31 | 14.50 | 117.11 | 75.35 | 90.94 | |
| Debt / Equity Ratio | 0.03 | 0.01 | 0.02 | 0.02 | 0.03 | 0.00 | |
| Asset Turnover | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Quick Ratio | 11.13 | 15.61 | 7.49 | 11.84 | 13.70 | 22.58 | |
| Current Ratio | 11.57 | 15.74 | 7.58 | 12.00 | 13.86 | 22.74 | |
| Return on Equity (ROE) | -32.44% | -33.47% | -39.34% | -36.27% | -34.32% | -23.62% | |
| Return on Assets (ROA) | -20.28% | -21.60% | -23.24% | -20.97% | -19.38% | -12.85% | |
| Return on Capital (ROIC) | -22.21% | -24.39% | -26.79% | -22.78% | -21.07% | -14.51% | |
| Return on Capital Employed (ROCE) | -31.20% | -25.90% | -43.00% | -30.50% | -29.70% | -13.90% | |
| Earnings Yield | -5.09% | -9.29% | -31.65% | -11.80% | -10.59% | -4.63% | |
| FCF Yield | -5.49% | -8.88% | -18.39% | -9.43% | -8.84% | -3.99% | |
| Buyback Yield / Dilution | -33.44% | -52.83% | -39.97% | -25.91% | -91.24% | -698.49% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.